1OKEN M, HARRINGTON D, ABRAMSON N, et al. Comparison of melphalan and prednisone with vincris- tine, camustine, melphalan, cyclophosphamide and prednisone in the treatment of multiple myeloma re- sults of Eastern cooperative Oncology Group study E2479[J]. Cancer, 1997,79 : 1561- 1567.
2BERGSAGEL D E. Chemotherapy of myeloma: drug combination seversus single agents. An overview and comments on acute leukemia in myeloma[J]. Hemato Oncol,1988,6:159-166.
5Rosner F,Grunwald HW.Multiple myeloma and Waldenstrom's macroglobulinemia terminating in acute leukemia.Review with emphasis on karyotypic and ultrastructural abnormalities.NY State J Med,1980;80(4):558-570.
6Mcintyre OR,Paajak TF,Wiernik P,et al.Delayed acute leukemia in myeloma patients receiving pulsed vs continuous treatment.Blood,1981;58(Suppl 1):167-168.
7Sheryl DM,Robert WM,Diane CA,et al.Therapy-related acute myeloid leukemia and myelodysplastic syndrome:a clinical and morphologic study of 65 cases.Blood,1986;65(6):1364-1372.
8Fred Rosner MD,Hans Grunwald MD.Multiple myeloma terminating in acute leukemia.The American Journal of Medicine,1974;57(6):927-939.
